Full metadata record
DC FieldValueLanguage
dc.contributor.authorSachdeva, Meenakshi-
dc.contributor.authorArora, Sunil K.-
dc.date.accessioned2020-12-16T14:57:40Z-
dc.date.available2020-12-16T14:57:40Z-
dc.date.issued2020-06-03-
dc.identifier.citationSachdeva, M., & Arora, S. K. (2020). Prognostic role of immune cells in hepatocellular carcinoma. EXCLI Journal, 19, 718-733. https://doi.org/10.17179/excli2020-2438de
dc.identifier.issn1611-2156-
dc.identifier.urihttp://hdl.handle.net/2003/39904-
dc.identifier.urihttp://dx.doi.org/10.17877/DE290R-21794-
dc.description.abstractHepatocellular carcinoma (HCC), with rising incidence rates, is the most commonly occurring malignancy of the liver that exerts a heavy disease burden particularly in developing countries. A dynamic cross-talk between immune cells and malignant cells in tumor microenvironment governs the hepatocarcinogenesis. Monitoring immune contexture as prognostic markers is quite relevant and essential to evaluate clinical outcomes and to envisage response to therapy. In this review, we present an overview of the prognostic value of various tumor infiltrating immune cells and the continually evolving immune checkpoints as novel biomarkers during HCC. Tumor infiltration by immune cells such as T cells, NK cells and dendritic cells is linked with improved prognosis and favorable outcome, while the intra-tumoral presence of regulatory T cells (Tregs) or myeloid derived suppressor cells (MDSCs) on the other hand is associated with poor clinical outcome. In addition to these, the overexpression of negative regulatory molecules on tumor cells also provides inhibitory signals to T cells and is associated with poor prognosis. The limitation of a single marker can be overcome by advanced prognostication models and algorithms that evaluate multiple prognostic factors and ultimately aid the clinician in improving the disease free and overall survival of HCC patients.en
dc.language.isoen-
dc.publisherIfADo - Leibniz Research Centre for Working Environment and Human Factors, Dortmundde
dc.relation.ispartofseriesEXCLI Journal;Vol. 19. 2020, pp. 718-733-
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/-
dc.subjectImmune cellsen
dc.subjectHepatocellular carcinomaen
dc.subjectPrognosisen
dc.subjectImmune checkpoint moleculesen
dc.subjectReviewen
dc.subject.ddc610-
dc.titlePrognostic role of immune cells in hepatocellular carcinomaen
dc.typeText-
dc.type.publicationtypearticle-
eldorado.identifier.urlhttps://doi.org/10.17179/excli2020-2438-
dcterms.accessRightsopen access-
eldorado.dnb.zdberstkatid2132560-1-
eldorado.dnb.zdberstkatidtrue-
Appears in Collections:Review Articles 2020

Files in This Item:
File Description SizeFormat 
excli2020-2438.pdfDNB548.18 kBAdobe PDFView/Open


This item is protected by original copyright



This item is licensed under a Creative Commons License Creative Commons